(Q54122750)

English

Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. (English)

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

0 references

pulmonary hypertension

1 reference

based on heuristic

inferred from title

Gérard Drobinski

2

object named as

Drobinski G

1 reference

Europe PubMed Central

25 May 2018

Gilles Montalescot

1

object named as

Montalescot G

1 reference

Europe PubMed Central

25 May 2018

author name string

Meurin P

3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Maclouf J

4

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Sotirov I

5

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Philippe F

6

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Choussat R

7

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Morin E

8

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Thomas D

9

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

American Journal of Cardiology

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

82

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

6

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

749-755

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Prostacyclin therapy in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Is there a role for epoprostenol in the management of heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Mechanics of pulmonary circulation in isolated rabbit lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Compliance of the Human Pulmonary Arterial System in Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Haemodynamic effects of intravenous urapidil in patients with advanced left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Factors affecting the pulmonary capillary blood flow pulse in man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Positive inotropic effect of a stable analogue of PGI2 and of PGI2 on isolated guinea pig atria. Mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Cyclic AMP-dependent and independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating isolated rat atria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

The development of positive inotropic agents for chronic heart failure: how have we gone astray?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900439-1

7 January 2021

Identifiers

10.1016/S0002-9149(98)00439-1

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9761085

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54122750&oldid=1532209799"